The miR-29-3p family (miR-29a, miR-29b, miR-29c) of
microRNAs is increased during
receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclastogenesis. In vivo, activation of a miR-29-3p tough decoy inhibitor in
Cre recombinase under the control of the
lysozyme 2 promoter-expressing cells (myeloid lineage) resulted in mice displaying enhanced trabecular and cortical bone volume because of decreased
bone resorption.
Calcitonin receptor (Calcr) is a miR-29 target that negatively regulates
bone resorption. CALCR was significantly increased in RANKL-treated miR-29-decoy osteoclasts, and these cells were more responsive to the inhibitory effect of
calcitonin on osteoclast formation. Further,
cathepsin K (Ctsk), which is critical for resorption, was decreased in miR-29-decoy cells. CALCR is a Gs-coupled receptor and its activation raises cAMP levels. In turn, cAMP suppresses
cathepsin K, and cAMP levels were increased in miR-29-decoy cells.
siRNA-mediated knock-down of Calcr in miR-29 decoy osteoclasts allowed recovery of
cathepsin K levels in these cells. Overall, using a novel knockin tough decoy mouse model, we identified a new role for miR-29-3p in bone homeostasis. In RANKL-driven osteoclastogenesis, as seen in normal bone remodeling, miR-29-3p promotes resorption. Consequently, inhibition of miR-29-3p activity in the myeloid lineage leads to increased trabecular and cortical bone. Further, this study documents an interrelationship between CALCR and CTSK in osteoclastic
bone resorption, which is modulated by miR-29-3p.